Stuttgart - Delayed Quote EUR

Reckitt Benckiser Group PLC (3RB.SG)

59.30

+1.54

+(2.67%)

At close: January 17 at 7:30:13 PM GMT+1

Reckitt to Boost US, China Production as Tariff Risks Loom

(Bloomberg) -- Reckitt Benckiser Plc is ramping up manufacturing in the US and China to bolster its supply chain and potentially lessen its exposure to fresh trade wars.Most Read from BloombergThese Homes Withstood the LA Fires. Architects Explain WhyAs E-Bikes Boom in NYC, Some Call for More RegulationsChicago Agency Pitches $1.5 Billion Plan to Fix Transit WoesNYPD Reforms Car Chase Policy Amid Rising Crashes, InjuriesChurches, Cinemas — and Moon Artifacts — Top List of Endangered MonumentsThe

Bloomberg 2 days ago

RBGLY
Best paying FTSE 100 stocks of 2024

London-listed firms that have served investors well delivering high yields.

Yahoo Finance UK 28 days ago

NWG

AZN

AZNCF
Reckitt bolsters US presence with new Wilson OTC facility

The new facility will help to boost Reckitt's production of Mucinex cold and flu relief to meet increased demand in the US.

Investment Monitor last month

RBGLY
Returns On Capital Are Showing Encouraging Signs At Reckitt Benckiser Group (LON:RKT)

What are the early trends we should look for to identify a stock that could multiply in value over the long term...

Simply Wall St. last month

RBGLY

RBGPF
Reckitt Prescribes More U.S. Production for Drug Supply Chain

The company is establishing a North Carolina factory for cold medicine as postpandemic pharma demand has grown more unpredictable.

The Wall Street Journal 2 months ago

RBGLY

RBGPF
Should We Be Delighted With Reckitt Benckiser Group plc's (LON:RKT) ROE Of 19%?

While some investors are already well versed in financial metrics (hat tip), this article is for those who would like...

Simply Wall St. 2 months ago

RBGLY

RBGPF
Bernstein downgrades Reckitt; litigation rollercoaster continues

Bernstein downgraded its investment stance on Reckitt Benckiser (LON:RKT), citing the continuation of a rollercoaster of litigation which has hit the consumer goods giant hard. At 08:15 ET (13:15 GMT), Reckitt stock fell 0.4% to £49.75, having fallen over 8% over the course of the year. “Reckitt shares have suffered from a rollercoaster over the past twelve months, driven in no small part by the NEC litigation in the US,” said analysts at Bernstein, in a note dated Nov. 4.

Investing.com 2 months ago

RBGLY
Abbott, Reckitt found not liable in baby formula case. Stocks rise.

A Missouri jury found Abbott Laboratories (ABT) and a unit of Reckitt Benckiser (RBGLY) not responsible for an infant death originally claimed to be tied to the company's baby formulas. The two health companies are seeing their shares rise on Friday following this legal victory. Market Domination's Julie Hyman and Josh Lipton report more on the story. To watch more expert insights and analysis on the latest market action, check out more Market Domination here. This post was written by Luke Carberry Mogan.

Yahoo Finance Video 2 months ago

RBGLY

RBGPF

ABT
Reckitt’s Mead Johnson, Abbott cleared by US court in infant-formula case

The Whitfield family legal case was just one of many still pending relating to the necrotizing enterocolitis (NEC) disease.

Just Food 2 months ago

RBGLY

ABT
Abbott, Reckitt Stocks Gain as Baby Formula Makers Score Rare Legal Win

Shares of Abbott Laboratories are rising and those of Reckitt Benckiser are gaining in London trading Friday, a day after a Missouri jury cleared the two infant formula makers of liability for a boy's debilitating intestinal disease.

Investopedia 2 months ago

ABT

RBGLY
Abbott, Reckitt Stocks Rise on Baby-Formula Lawsuit Win

Shares of Abbott Laboratories and Reckitt Benckiser rose after the companies won a victory in litigation over the safety of some baby-formula products. Abbott shares rose 4% in early New York trading, while Reckitt’s shares were up 8% in London. A jury in Missouri state court found Reckitt’s Mead Johnson unit and Abbott weren't liable for injuries suffered by a boy who consumed their formulas designed for premature babies, following a civil trial.

The Wall Street Journal 2 months ago

RBGLY

RBGPF

ABT
Friday's FTSE 100 risers and fallers: Tesco, Frasers and EasyJet

Investor updates on the companies trending on the UK blue-chip index on Friday.

Yahoo Finance UK 2 months ago

^FTSE

DITHF

DSSMY
Abbott shares rise after securing first win in premature infant formula trial

A jury in St. Louis, Missouri found on Thursday that Abbott and Reckitt unit Mead Johnson are not responsible for a young boy's severe intestinal disease, marking the first victory for the companies after large losses in two previous trials. The lawsuit was one of about 1,000 similar cases pending nationwide over allegations the companies failed to warn that their specialized formulas used by newborn intensive care units in hospitals could cause necrotizing enterocolitis (NEC). NEC almost exclusively affects premature infants and has an estimated mortality rate of more than 20%.

Reuters 2 months ago

ABT

RBGLY
Reckitt, Abbott Shares Rise After Baby-Formula Lawsuit Win

Shares in Reckitt Benckiser topped the Stoxx Europe 600 Index after a U.S. court cleared the company of liability in a case concerning its baby formulas.

The Wall Street Journal 2 months ago

ABT

RBGLY

RBGPF
Reckitt, Abbott surge after winning an NEC case

Investing.com -- A jury ruled on Thursday that Abbott Laboratories (NYSE:ABT) and Mead Johnson, a division of Reckitt Benckiser (LON:RKT), are not liable for a young boy's severe intestinal disease, marking a significant win for the companies after substantial losses in similar cases.

Investing.com 2 months ago

ABT

RBGLY
Jury asked to award more than $6 billion in preterm formula case against Abbott, Reckitt's Mead

(Reuters) -A lawyer for a Missouri mother on Wednesday asked a jury to make Abbott and Reckitt's Mead Johnson pay a total of more than $6 billion in the latest trial over claims that the companies' formulas for premature babies caused a severe intestinal illness. Abbott CEO Robert Ford has told investors that it may pull its premature infant formula from the market because of the litigation. Reckitt in July said it was "considering options" for Mead Johnson, and CEO Kris Licht did not rule out a sale.

Reuters 2 months ago

RBGLY
Reckitt sees sales of new hyaluronic acid condoms surge in China

Reckitt launched its first hyaluronic acid-lubricated Durex condoms across China in October 2022.

PA Media: Money 2 months ago

RBGLY
The past five-year earnings decline for Reckitt Benckiser Group (LON:RKT) likely explains shareholders long-term losses

While not a mind-blowing move, it is good to see that the Reckitt Benckiser Group plc ( LON:RKT ) share price has...

Simply Wall St. 2 months ago

RBGLY

RBGPF
Tesla profits jump amid rebound in demand for electric cars

Elon Musk’s Tesla has revealed an unexpected rise in profits in a sign of rebounding demand for electric cars.

The Telegraph 2 months ago

COMP

^FTSE

^GSPC
RBGLY or CLX: Which Is the Better Value Stock Right Now?

RBGLY vs. CLX: Which Stock Is the Better Value Option?

Zacks 2 months ago

RBGLY

CLX

Performance Overview

Return	3RB.SG	FTSE 100
YTD	+2.14%	+4.73%
1-Year	-6.13%	+12.53%
3-Year	-13.23%	+12.76%

News

Life

Entertainment

Finance

Sports

New on Yahoo

Yahoo Finance

Reckitt Benckiser Group PLC (3RB.SG)

Reckitt to Boost US, China Production as Tariff Risks Loom

Best paying FTSE 100 stocks of 2024

Reckitt bolsters US presence with new Wilson OTC facility

Returns On Capital Are Showing Encouraging Signs At Reckitt Benckiser Group (LON:RKT)

Reckitt Prescribes More U.S. Production for Drug Supply Chain

Should We Be Delighted With Reckitt Benckiser Group plc's (LON:RKT) ROE Of 19%?

Bernstein downgrades Reckitt; litigation rollercoaster continues

Abbott, Reckitt found not liable in baby formula case. Stocks rise.

Reckitt’s Mead Johnson, Abbott cleared by US court in infant-formula case

Abbott, Reckitt Stocks Gain as Baby Formula Makers Score Rare Legal Win

Abbott, Reckitt Stocks Rise on Baby-Formula Lawsuit Win

Friday's FTSE 100 risers and fallers: Tesco, Frasers and EasyJet

Abbott shares rise after securing first win in premature infant formula trial

Reckitt, Abbott Shares Rise After Baby-Formula Lawsuit Win

Reckitt, Abbott surge after winning an NEC case

Jury asked to award more than $6 billion in preterm formula case against Abbott, Reckitt's Mead

Reckitt sees sales of new hyaluronic acid condoms surge in China

The past five-year earnings decline for Reckitt Benckiser Group (LON:RKT) likely explains shareholders long-term losses

Tesla profits jump amid rebound in demand for electric cars

RBGLY or CLX: Which Is the Better Value Stock Right Now?

Performance Overview